EAST LANSING, Mich. (WILX) - A grant to expand research into a rare genetic disorder has been announced from the Bow Foundation.
The foundation plans to grant MSU's Department of Pharmacology and Toxicology $48,000.
Through the study, researchers will gather more information about GNAO1, test existing drugs, and identify possible new treatment options.
The project will be led by Dr. Richard Neubig.
“Dr. Neubig’s research gives the promise of hope to the dozens of GNAO1 patients around the world,” Bow Foundation co-chairs Emily Bell and Alice Fox said in a statement. “By helping the medical community better understand the impact of GNAO1-related neurodevelopmental disorders, it could also open doors to better treatment options for patients. We’re excited to fund this new research project and are thrilled to be working with Michigan State. We look forward to gaining new insights and funding additional studies as we work to increase GNAO1 awareness and change lives.”
The lab will develop mice to carry two or more of the mutation genes, be analyzed and go through clinical trials.
“We look forward to working with the Bow Foundation to better understand the consequences of GNAO1 mutations on child brain development and to try to identify new therapeutic options,” Dr. Neubig said. “Their support of families of children with this rare disorder and their support of research to help these children makes a huge difference.”
This is the second major Bow Foundation medical research grant. The foundation previously funded a $100,000 GNAO1 stem cell research study at the University of Virginia’s School of Medicine.